Atlas Trials

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

Clinical trial NCT07331428 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07331428
Sponsor
Fujian Cancer Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal CarcinomaLocal Recurrence
Start date
2026-01-01
Primary completion
2027-12-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.